Patents - Global Data - Dimensions
MAMMALIAN CELL LINE FOR THE PRODUCTION OF MODIFIED VACCINIA VIRUS ANKARA (MVA)
Applicants:
- Bavarian Nordic (Denmark) [NORA names: Bavarian Nordic; Private Research; Denmark; Europe, EU; Nordic; OECD]
Abstract
The present invention relates to a mammalian non-human cell line, specifically Chinese hamster ovary (CHO) cells, that is genetically modified to express poxvirus host range genes CP77, K1 L and/or SPI-1 which are not expressed in MVA, and to the use of said cell line in the reproduction of MVA.
Patent Family Records (1)
MAMMALIAN CELL LINE FOR THE PRODUCTION OF MODIFIED VACCINIA VIRUS ANKARA (MVA)
BAVARIAN NORDIC AS, Bavarian Nordic (Denmark) STEIGERWALD ROBIN, XU ZHIYONG, HAUSMANN JÜRGEN
2024, WO-2024003346-A1
